These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9036795)

  • 21. Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
    Veldhuyzen van Zanten S; Hunt RH; Cockeram A; Schep G; Malatjalian D; Sidorov J; Matisko A; Jewell D
    Am J Gastroenterol; 1998 Jan; 93(1):5-10. PubMed ID: 9448164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of Helicobacter pylori infections].
    Calvet Calvo X
    Gastroenterol Hepatol; 1998 Apr; 21(4):203-6. PubMed ID: 9633184
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment strategies for Helicobacter pylori infection.
    Damianos AJ; McGarrity TJ
    Am Fam Physician; 1997 Jun; 55(8):2765-74, 2784-6. PubMed ID: 9191460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of omeprazole and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the healing of duodenal ulcer: comparison with a historical control.
    Schütze K; Hentschel E; Hirschl AM
    Hepatogastroenterology; 1999; 46(28):2358-62. PubMed ID: 10521998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of Helicobacter pylori infection].
    Lamouliatte H; Cayla R; Mégraud F
    Rev Prat; 2000 Sep; 50(13):1442-5. PubMed ID: 11019637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial of triple therapy for pediatric Helicobacter pylori infection and risk factors for treatment failure in a population with a high prevalence of infection.
    Gessner BD; Bruce MG; Parkinson AJ; Gold BD; Muth PT; Dunaway E; Baggett HC
    Clin Infect Dis; 2005 Nov; 41(9):1261-8. PubMed ID: 16206100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection.
    Chan KL; Zhou H; Ng DK; Tam PK
    J Pediatr Surg; 2001 Jul; 36(7):1008-11. PubMed ID: 11431766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori: a clinical update.
    Moayyedi P; Murphy B
    Symp Ser Soc Appl Microbiol; 2001; (30):126S-33S. PubMed ID: 11422568
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
    Lerang F; Moum B; Ragnhildstveit E; Haug JB; Hauge T; Tolås P; Aubert E; Henriksen M; Efskind PS; Nicolaysen K; Søberg T; Odegaard A; Berge T
    Am J Gastroenterol; 1997 Apr; 92(4):653-8. PubMed ID: 9128317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter hepaticus, a recently recognized bacterial pathogen, associated with chronic hepatitis and hepatocellular neoplasia in laboratory mice.
    Rice JM
    Emerg Infect Dis; 1995; 1(4):129-31. PubMed ID: 8903182
    [No Abstract]   [Full Text] [Related]  

  • 31. HELIDAC therapy (bismuth subsalicylate/metronidazole/tetracycline hydrochloride).
    Claussen DW
    Gastroenterol Nurs; 1997; 20(5):188-9. PubMed ID: 9384064
    [No Abstract]   [Full Text] [Related]  

  • 32. Acne rosacea and Helicobacter pylori betrothed.
    Wolf R
    Int J Dermatol; 1996 Apr; 35(4):302-3. PubMed ID: 8786195
    [No Abstract]   [Full Text] [Related]  

  • 33. Eradicating Helicobacter pylori.
    Rautelin H; Kosunen TU; Seppälä K
    Lancet; 1992 Jan; 339(8784):55. PubMed ID: 1345968
    [No Abstract]   [Full Text] [Related]  

  • 34. Primary resistance to metronidazole and other antibiotics of Helicobacter pylori isolated from children in Poland.
    Rozynek E; Dzierzanowska D; Celińska-Cedro D; Jeljaszewicz J
    Eur J Clin Microbiol Infect Dis; 1997 Dec; 16(12):943-4. PubMed ID: 9495680
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapy in Helicobacter pylori infection.
    Lancet; 1990 Dec; 336(8727):1380-1. PubMed ID: 1978187
    [No Abstract]   [Full Text] [Related]  

  • 36. Helicobacter pylori: related to rosacea?
    Grilli R
    J Am Acad Dermatol; 2000 Mar; 42(3):536-7. PubMed ID: 10688738
    [No Abstract]   [Full Text] [Related]  

  • 37. On the efficacy of penicillins for Helicobacter pylori eradication.
    Cennamo V; Morace C; Ceroni L; Fabbri C
    Panminerva Med; 2011 Jun; 53(2):137. PubMed ID: 21659978
    [No Abstract]   [Full Text] [Related]  

  • 38. Antimicrobial resistance and Helicobacter pylori.
    Goddard AF; Logan RP
    J Antimicrob Chemother; 1996 Apr; 37(4):639-43. PubMed ID: 8722530
    [No Abstract]   [Full Text] [Related]  

  • 39. Galenic formulations and Helicobacter pylori eradication.
    Boixeda D; Martin-de-Argila C; Cantón R; de Rafael L; Baquero F
    Scand J Gastroenterol; 1996 Jul; 31(7):736. PubMed ID: 8819227
    [No Abstract]   [Full Text] [Related]  

  • 40. [Eradication treatment of Helicobacter pylori in children with triple therapy: can we do it in two weeks? Letter].
    Díez Domingo J; Pereiró Berenguer I
    An Esp Pediatr; 1996 Nov; 45(5):549. PubMed ID: 9036794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.